Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK1 | P49759 | 2/20 | 0.60 |
| ▸ | CDC7 | O00311 | 2/20 | 0.50 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.45 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.42 |
| ▸ | FEN1 | P39748 | 2/20 | 0.42 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.41 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.41 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2648750 | 0.83 | PIK3CA (0.46) | CLK1TDP1ALDH1A1HIF1ACDK2 | |
| SCHEMBL31119106 | 0.83 | PIK3CA (0.46) | CLK1TDP1ALDH1A1HIF1ACDK2 | |
| SCHEMBL20265102 | 0.81 | CLK1 (0.60) | CLK1CDC7ROCK1GSK3BCDK5 | |
| SCHEMBL18495643 | 0.77 | FEN1 (0.48) | CLK1CDC7GSK3BCDK5CDK5R1 | |
| SCHEMBL4526945 | 0.76 | ROCK1 (0.57) | CLK1CDC7ROCK1ALDH1A1PIK3CA | |
| SCHEMBL30775416 | 0.76 | MAP3K14 (0.57) | CDC7ROCK1GSK3BCDK5CDK5R1 | |
| SCHEMBL2658617 | 0.76 | ALDH1A1 (0.45) | TDP1ALDH1A1HIF1AAMY1AMAPT | |
| SCHEMBL30369564 | 0.76 | CLK1 (1.00) | CLK1GSK3BCDK5CDK5R1CDK2 | |
| SCHEMBL30369770 | 0.76 | CLK1 (0.82) | CLK1GSK3BCDK5CDK5R1MAP3K14 | |
| SCHEMBL28982761 | 0.76 | CLK1 (1.00) | CLK1GSK3BCDK5CDK5R1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3331885-B1 | COMPOUNDS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2020-12-23 | — | — | EP | disclosed |
| CN-108137599-B | Compound (I) | 葛兰素史密斯克莱知识产权发展有限公司 | 2020-10-27 | — | — | CN | disclosed |
| US-10479792-B2 | Compounds | GiaxoSmithKline Intellectual Property Development Limited (GB) | 2019-11-19 | — | — | US | disclosed |
| US-10479792-B2 | Compounds | GiaxoSmithKline Intellectual Property Development Limited (GB) | 2019-11-19 | — | — | US | disclosed |
| US-20180222911-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-08-09 | — | — | US | disclosed |
| US-20180222911-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-08-09 | — | — | US | disclosed |
| US-20180222911-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-08-09 | — | — | US | disclosed |
| EP-3331885-A1 | COMPOUNDS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2018-06-13 | — | — | EP | disclosed |
| WO-2017025416-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-02-16 | — | — | WO | disclosed |
| WO-2017025416-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222911-A1 | COMPOUNDS | TBCA, MPO, GOT1 | CLK1 3040/4885CDC7 4393/4885ROCK1 3557/4885 |
| US-10479792-B2 | Compounds | TBCA, MPO, GOT1 | CLK1 3040/4885CDC7 4393/4885ROCK1 3557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.